Research Impact

h-index

N/A

Research impact score

Publications

Total publications

Trial Results

Published trial results

Citations

Total citations

Drug Portfolio

MIXED(2)

DRUG(1)

MRI IMAGING

1 trial

not_applicable

danafarber-cancer-institute

Radiotherapy

1 trial

phase_1_2

danafarber-cancer-institute

AGuIX

1 trial

phase_1_2

danafarber-cancer-institute

3 unique interventions2 categories

Analytics

Trial Phases

Phase 11

Phase 21

Trial Status

Recruiting2

Role Distribution

Principal Investigator2

PI Rate100%

Activity Timeline

Clinical Trials (2)

NCT04789486Phase 1/2Recruiting

Nano-SMART: Nanoparticles With MR Guided SBRT in Centrally Located Lung Tumors and Pancreatic Cancer

Advanced Pancreatic AdenocarcinomaDuctal Adenocarcinoma of the PancreasNon-small Cell Lung Cancer+1 more

PrincipalinvestigatorStart date: 2021-05-27

NCT04188535Not ApplicableRecruiting

Serial MRI Scans During Radiation Therapy

Esophageal CancerGlioblastomaMagnetic Resonance Imaging+6 more

PrincipalinvestigatorStart date: 2020-01-15

Research Network

Collaboration Network

1 collaborators·0 connections

Network Legend

KOL

Current Investigator

High-influence Collaborator

Collaborator

Click: view details

Double-click: go to profile

Drag: move node

Research Areas & Affiliations

Therapeutic Areas

Advanced Pancreatic Adenocarcinoma1 Ductal Adenocarcinoma of the Pancreas1 Cancer of Esophagus1 Glioblastoma1 Magnetic Resonance Imaging1 MRI1 Carcinoma, Non-Small-Cell Lung1 Pediatric Glioblastoma Multiforme1

Affiliations

Dana-Farber Cancer Institute

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Michael B Gill

Power Life Sciences Inc.

105 trials

Shared therapeutic areas:

Cancer of EsophagusGlioblastomaCarcinoma, Non-Small-Cell Lung+1 more

Similarity Score9%

Zhenfeng Zhang, MD, PhD

Second Affiliated Hospital of Guangzhou Medical University

21 trials

Shared therapeutic areas:

Carcinoma, Non-Small-Cell LungCancer of EsophagusSarcoma

Similarity Score7%

Mark Levine, MD

Ontario Clinical Oncology Group (OCOG)

13 trials

Shared therapeutic areas:

Prostate CancerCancer of EsophagusCarcinoma, Non-Small-Cell Lung

Similarity Score7%

David S Schrump, M.D.

National Cancer Institute (NCI)

21 trials

Shared therapeutic areas:

SarcomaCarcinoma, Non-Small-Cell LungCancer of Esophagus

Similarity Score7%

Dong-Xin Wang, MD, PhD

Peking University First Hospital

74 trials

Shared therapeutic areas:

Carcinoma, Non-Small-Cell LungProstate Cancer

Similarity Score5%

Steven A Rosenberg, M.D.

National Cancer Institute (NCI)

32 trials

Shared therapeutic areas:

Carcinoma, Non-Small-Cell LungGlioblastoma

Similarity Score5%

Zhaohui Zhu, MD

Peking Union Medical College Hospital

19 trials

Shared therapeutic areas:

Prostate CancerCarcinoma, Non-Small-Cell Lung

Similarity Score5%

Stanislaw R. Burzynski, MD, PhD

Burzynski Research Institute

62 trials

Shared therapeutic areas:

Prostate CancerSarcoma

Similarity Score5%

John D. Hainsworth, MD

SCRI Development Innovations, LLC

26 trials

Shared therapeutic areas:

Prostate CancerCancer of Esophagus

Similarity Score5%

Aminah Jatoi, MD

Mayo Clinic

29 trials

Shared therapeutic areas:

Cancer of EsophagusProstate Cancer

Similarity Score5%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT04789486Phase 1/2PrincipalInvestigator

Nano-SMART: Nanoparticles With MR Guided SBRT in Centrally Located Lung Tumors and Pancreatic Cancer

Advanced Pancreatic AdenocarcinomaDuctal Adenocarcinoma of the PancreasNon-small Cell Lung Cancer+1 more

Recruiting

NCT04188535Not ApplicablePrincipalInvestigator

Serial MRI Scans During Radiation Therapy

Esophageal CancerGlioblastomaMagnetic Resonance Imaging+6 more

Recruiting

All 2 trials loaded